Viewing Study NCT06311851


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2025-12-25 @ 9:31 PM
Study NCT ID: NCT06311851
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2024-03-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
Sponsor: Pardis Noor Medical Imaging and Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module